Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.

Lee JH, Jeon EJ, Kim N, Nam YS, Im KI, Lim JY, Kim EJ, Cho ML, Han KT, Cho SG.

PLoS One. 2013 Aug 5;8(8):e70968. doi: 10.1371/journal.pone.0070968. Print 2013.

2.

Control of allograft rejection in mice by applying a novel neuropeptide, cortistatin.

Wang J, Zhao R, Zhang F, Li J, Huo B, Cao Y, Dou K.

Adv Ther. 2008 Dec;25(12):1331-41. doi: 10.1007/s12325-008-0121-z.

PMID:
19034397
3.
4.

Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.

Kim YH, Wee YM, Choi MY, Lim DG, Kim SC, Han DJ.

Mol Med. 2011;17(7-8):697-708. doi: 10.2119/molmed.2010.00098. Epub 2011 Feb 25.

5.

Stro-1-positive human mesenchymal stem cells prolong skin graft survival in mice.

Zhang Y, Zhao D, Tian C, Li F, Li X, Zhang L, Yang H.

Transplant Proc. 2013 Mar;45(2):726-9. doi: 10.1016/j.transproceed.2012.06.086.

PMID:
23498813
6.

CD4(+)CD25 (+) regulatory T cells are not required for mesenchymal stem cell function in fully MHC-mismatched mouse cardiac transplantation.

Jiang X, Liu C, Hao J, Guo D, Guo J, Yao J, Jiang K, Cui Z, Zhu L, Sun W, Lin L, Liang J.

Cell Tissue Res. 2014 Nov;358(2):503-14. doi: 10.1007/s00441-014-1956-z. Epub 2014 Aug 8.

PMID:
25103227
7.

Music exposure induced prolongation of cardiac allograft survival and generated regulatory CD4⁺ cells in mice.

Uchiyama M, Jin X, Zhang Q, Amano A, Watanabe T, Niimi M.

Transplant Proc. 2012 May;44(4):1076-9. doi: 10.1016/j.transproceed.2012.02.008.

PMID:
22564629
8.

Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.

Teng L, Liu L, Su Y, Yuan X, Li J, Fu Q, Chen S, Wang C.

J Surg Res. 2011 Dec;171(2):797-806. doi: 10.1016/j.jss.2010.03.044. Epub 2010 Apr 15.

PMID:
20538297
9.

Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.

Ge W, Jiang J, Baroja ML, Arp J, Zassoko R, Liu W, Bartholomew A, Garcia B, Wang H.

Am J Transplant. 2009 Aug;9(8):1760-72. doi: 10.1111/j.1600-6143.2009.02721.x. Epub 2009 Jun 26.

10.

Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.

Jia Z, Jiao C, Zhao S, Li X, Ren X, Zhang L, Han ZC, Zhang X.

Exp Eye Res. 2012 Sep;102:44-9. doi: 10.1016/j.exer.2012.06.008. Epub 2012 Jul 16.

PMID:
22800963
11.

Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts.

Khattar M, Deng R, Kahan BD, Schroder PM, Phan T, Rutzky LP, Stepkowski SM.

Transplantation. 2013 Apr 15;95(7):919-27. doi: 10.1097/TP.0b013e3182842396.

12.

Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.

Wang X, Wang W, Xu J, Le Q.

Transplant Proc. 2013 Mar;45(2):528-37. doi: 10.1016/j.transproceed.2012.06.064. Epub 2012 Sep 13.

PMID:
23267787
13.

Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion.

Wang Y, Zhang A, Ye Z, Xie H, Zheng S.

Transplant Proc. 2009 Dec;41(10):4352-6. doi: 10.1016/j.transproceed.2009.08.072.

PMID:
20005397
14.

Presensitized immune condition of host exaggerates prolonged cold ischemia-mediated injury of cardiac graft involving regulatory T cells.

Gong W, Huang T, Ge F, Luo G, Yuan S, Gao D, Kong D.

Transplantation. 2013 Oct 15;96(7):609-15. doi: 10.1097/TP.0b013e31829df26d.

PMID:
23880577
15.

Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.

Ma A, Qi S, Wang Z, Massicotte E, Dupuis M, Daloze P, Chen H.

Int Immunopharmacol. 2009 May;9(5):553-63. doi: 10.1016/j.intimp.2009.01.033. Epub 2009 Feb 8.

PMID:
19539558
16.

[Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].

Qi BD, Meng BX, Yang Y, Liu B, Li CC, Xia W, Guo SZ, Zhang C.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2011 May;27(3):207-12. Chinese.

PMID:
21838003
17.

rFliC prolongs allograft survival in association with the activation of recipient Tregs in a TLR5-dependent manner.

Hao J, Zhang C, Liang T, Song J, Hou G.

Cell Mol Immunol. 2014 Mar;11(2):206-14. doi: 10.1038/cmi.2013.44. Epub 2013 Oct 7.

18.

Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses.

Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Mariño E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST.

J Immunol. 2009 Jan 15;182(2):793-801.

19.

Artemisiae capillaris herba induces prolonged survival of fully cardiac allografts and generates regulatory cells in mice.

Jin X, Uchiyama M, Zhang Q, Watanabe T, Niimi M.

Transplant Proc. 2012 May;44(4):1073-5. doi: 10.1016/j.transproceed.2012.03.002.

PMID:
22564628
20.

[Immunomodulatory effects of human placental-derived mesenchymal stem cells on immune rejection in mouse allogeneic skin transplantation].

Wang Q, Liu T, Zhang Y, Chen D, Wang L, Li Y, Wei J.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Jul;27(7):775-80. Chinese.

PMID:
24063162

Supplemental Content

Support Center